The current price of ILMN is $213.10 — it has decreased by 5.93% since the previous close. Data as of Nov 5, 2026.
ILMN is down 17.23% over the past week, down 27.92% over the past month and up 72.90% over the past year. The price is above its 200-day moving average of $177.39.
In its most recent quarterly report, Illumina, Inc. posted earnings of $1.62 per share against an estimate of $1.36, beating expectations by 19.12%. Upcoming reports are listed in the earnings calendar.
Illumina, Inc. reported revenue of $1.17B in its most recent quarter, which has increased by 7.66% compared with the same quarter a year earlier. Analysts had expected $1.15B.
Illumina, Inc. has not paid any dividends over the past year.
Companies most comparable to Illumina, Inc. include Natera, Inc., Guardant Health, Inc., 10x Genomics, Inc., BillionToOne, Inc. and NeoGenomics, Inc.
In the latest trading session ILMN moved between $205.84 and $221.48, a range of 7.34% of its current price.
Investing in stocks requires thorough research: study the company's financials, related news and technical analysis before making a decision. Technical analysis of Illumina, Inc. shows a sell rating today. Technical ratings are indicators, not investment advice.
Over the past 52 weeks ILMN has traded between $112.65 and $309.35. The current price is 31.12% below its 52-week high.
Figures as of Nov 5, 2026. This information is provided for general purposes only and is not investment advice.